These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20448003)

  • 1. Failure to discount for conflict of interest when evaluating medical literature: a randomised trial of physicians.
    Silverman GK; Loewenstein GF; Anderson BL; Ubel PA; Zinberg S; Schulkin J
    J Med Ethics; 2010 May; 36(5):265-70. PubMed ID: 20448003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the need for probity when physicians interact with industry.
    Scott IA
    Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A survey of obstetrician-gynecologists concerning practice patterns and attitudes toward hormone therapy.
    Power ML; Zinberg S; Schulkin J
    Menopause; 2006; 13(3):434-41. PubMed ID: 16735940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Under the radar": nurse practitioner prescribers and pharmaceutical industry promotions.
    Ladd EC; Mahoney DF; Emani S
    Am J Manag Care; 2010 Dec; 16(12):e358-62. PubMed ID: 21291293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.
    Gray SW; Hlubocky FJ; Ratain MJ; Daugherty CK
    J Clin Oncol; 2007 Aug; 25(23):3488-94. PubMed ID: 17687154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
    Huddle TS
    Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
    [No Abstract]   [Full Text] [Related]  

  • 11. Professionalism and conflict of interest in new technology introduction.
    Hanley EN
    Am J Orthop (Belle Mead NJ); 2007 Aug; 36(8):398-9. PubMed ID: 17849023
    [No Abstract]   [Full Text] [Related]  

  • 12. Gynecologists' attitudes towards hormone therapy in the post "Women's Health Initiative" study era.
    Nassar AH; Abd Essamad HM; Awwad JT; Khoury NG; Usta IM
    Maturitas; 2005 Sep; 52(1):18-25. PubMed ID: 16143222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Getting drug money out of doctors' offices...
    Nagarkar PA
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(1):13-7. PubMed ID: 20178201
    [No Abstract]   [Full Text] [Related]  

  • 14. Do ethical Guidelines make a difference to decision-making?
    Osborn M; Day R; Komesaroff P; Mant A
    Intern Med J; 2009 Dec; 39(12):800-5. PubMed ID: 19323704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing conflicts of interest and commitment: academic medicine and the physician's progress.
    Kachuck NJ
    J Med Ethics; 2011 Jan; 37(1):2-5. PubMed ID: 21149321
    [No Abstract]   [Full Text] [Related]  

  • 16. Doctors and the drug industry: further thoughts for dealing with potential conflicts of interest?
    Alpert JS
    Am J Med; 2008 Apr; 121(4):253-5. PubMed ID: 18374678
    [No Abstract]   [Full Text] [Related]  

  • 17. Icebreakers-unexpected outcomes.
    Jamshed SQ; Mohamed Ibrahim MI; Hassali MA
    J Coll Physicians Surg Pak; 2010 Feb; 20(2):142. PubMed ID: 20378048
    [No Abstract]   [Full Text] [Related]  

  • 18. Re "Getting drug money out of doctors' offices".
    Jacobs J
    Pharos Alpha Omega Alpha Honor Med Soc; 2010; 73(3):50; author reply 50-1. PubMed ID: 20690557
    [No Abstract]   [Full Text] [Related]  

  • 19. Hormone replacement therapy: a survey of Ontario physicians' prescribing practices.
    Elinson L; Cohen MM; Elmslie T
    CMAJ; 1999 Sep; 161(6):695-8. PubMed ID: 10513275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Professionalism and physician interactions with industry.
    Collins J
    J Am Coll Radiol; 2006 May; 3(5):325-32. PubMed ID: 17412075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.